PKI Solutions has reported a substantial transfer of 6,00,000 equity shares in Vivo Bio Tech Limited. The transaction, which occurred on August 21, 2026, involved M/s. P.K.L Solution Private Limited. This disclosure is made in accordance with Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, providing transparency on significant shareholding changes.
Significant Share Transfer Reported
PKI Solutions, through its associated entity P.K.L Solution Private Limited, has formally disclosed a significant transaction involving 6,00,000 equity shares of Vivo Bio Tech Limited. This transfer of shares took place on August 21, 2026, and is being reported as per the requirements of Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Disclosure Details
The disclosure highlights that prior to the transaction, M/s. P.K.L Solution Private Limited held 6,00,000 equity shares, representing 2.70% of the total share capital and 2.05% of the diluted share capital of Vivo Bio Tech Limited. Following the acquisition, the holding remains unchanged in terms of number of shares and percentage, indicating a transfer between parties rather than an acquisition or disposal from the open market. The total diluted share capital of Vivo Bio Tech Limited after the transaction is stated to be 2,93,23,111 equity shares.
The document also clarifies that the equity share capital of Vivo Bio Tech Limited, before and after the said acquisition/sale, remains at 2,21,90,628 equity shares, aggregating to Rs. 22,19,06,280. The mode of acquisition/sale is listed as ‘Off Market’.
Source: BSE
